Osmosis Investment Management UK Ltd Acquires Shares of 10,336 Synopsys, Inc. $SNPS

Osmosis Investment Management UK Ltd bought a new position in Synopsys, Inc. (NASDAQ:SNPS) during the 2nd quarter, HoldingsChannel.com reports. The fund bought 10,336 shares of the semiconductor company’s stock, valued at approximately $4,611,000.

A number of other large investors have also made changes to their positions in the company. Sanctuary Advisors LLC purchased a new stake in Synopsys in the 2nd quarter worth about $4,111,000. Covington Investment Advisors Inc. purchased a new position in Synopsys during the 2nd quarter valued at about $9,190,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Synopsys in the 2nd quarter valued at about $201,902,000. Meiji Yasuda Asset Management Co Ltd. acquired a new position in shares of Synopsys in the 2nd quarter valued at about $670,000. Finally, Bank of Nova Scotia acquired a new position in Synopsys in the 2nd quarter valued at approximately $95,816,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by corporate insiders.

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $397.87 on Monday. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79. The business has a 50-day moving average of $419.73 and a two-hundred day moving average of $440.09. The stock has a market capitalization of $76.18 billion, a P/E ratio of 92.10, a P/E/G ratio of 2.34 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the prior year, the firm posted $3.67 EPS. The firm’s revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on SNPS shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Citigroup upped their price target on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Rosenblatt Securities increased their price objective on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a report on Tuesday, May 26th. Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Finally, BNP Paribas Exane upped their target price on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research report on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Synopsys currently has an average rating of “Moderate Buy” and an average target price of $563.59.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.